We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+40.48%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$565M
AUM Growth
+$183M
Cap. Flow
+$64.7M
Cap. Flow %
11.44%
Top 10 Hldgs %
66.34%
Holding
79
New
22
Increased
9
Reduced
6
Closed
5
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$55.2M
2
EOSE icon
Eos Energy Enterprises
EOSE
+$5.07M
3
LIQT icon
LiqTech
LIQT
+$4.94M
4
LSXMA icon
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$3.45M
5
FATE icon
Fate Therapeutics
FATE
+$2.39M

Top Sells

Rank Stock Value
1
WELL icon
Welltower
WELL
+$6.7M
2
FLNA icon
Filana Therapeutics
FLNA
+$3.13M
3
PYPL icon
PayPal
PYPL
+$2.42M
4
IHC
Independence Holding Company
IHC
+$1.12M
5
RTN
Raytheon Company
RTN
+$566K

Sector Composition

Rank Sector Weight
1 Healthcare 28.61%
2 Industrials 14.54%
3 Miscellaneous 14.26%
4 Energy 11.06%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CDNA icon
26
CareDx
CDNA
$3.47B
$4.43M 0.78%
125,000
+25,000
+25% +$711K
2019 Q4
2 quarters
CUE icon
27
Cue Biopharma
CUE
$133M
$4.04M 0.72%
5,500
– –
2019 Q4
2 quarters
LSXMA icon
28
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.58M 0.63%
+141,002
New +$3.45M
2020 Q2
0 quarters
BLFS icon
29
DELISTED
BioLife Solutions
BLFS
$3.46M 0.61%
211,942
– –
2020 Q1
1 quarter
FLNA icon
30
Filana Therapeutics
FLNA
$35.5M
$3.24M 0.57%
1,050,503
-689,037
-40% -$3.13M
2019 Q4
2 quarters
JPM icon
31
JPMorgan Chase
JPM
$889B
$2.82M 0.5%
30,000
– –
2019 Q4
2 quarters
FATE icon
32
Fate Therapeutics
FATE
$231M
$2.75M 0.49%
+80,028
New +$2.39M
2020 Q2
0 quarters
DISH
33
DELISTED
DISH Network Corp.
DISH
$2.67M 0.47%
77,500
– –
2020 Q1
1 quarter
DNTH icon
34
Dianthus Therapeutics
DNTH
$4.16B
$2.64M 0.47%
21,992
+6,250
+40% +$881K
2020 Q1
1 quarter
AMP icon
35
Ameriprise Financial
AMP
$43.8B
$2.4M 0.42%
15,993
– –
2019 Q4
2 quarters
AXP icon
36
American Express
AXP
$211B
$2.38M 0.42%
25,000
– –
2019 Q4
2 quarters
EPD icon
37
Enterprise Products Partners
EPD
$77.1B
$2.29M 0.41%
126,301
– –
2019 Q4
2 quarters
OIG
38
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2.29M 0.41%
92,514
– –
2019 Q4
2 quarters
DUOT icon
39
Duos Technologies
DUOT
$174M
$2.09M 0.37%
453,616
– –
2020 Q1
1 quarter
IHC
40
DELISTED
Independence Holding Company
IHC
$1.67M 0.3%
54,711
-40,236
-42% -$1.12M
2019 Q4
2 quarters
BLUE icon
41
DELISTED
bluebird bio
BLUE
$1.53M 0.27%
+1,930
New +$1.46M
2020 Q2
0 quarters
LBTYK icon
42
Liberty Global Class C
LBTYK
$2.7B
$1.5M 0.26%
69,618
– –
2019 Q4
2 quarters
RIBT
43
DELISTED
RiceBran Technologies
RIBT
$1.41M 0.25%
170,333
-30,000
-15% -$329K
2019 Q4
2 quarters
GRTS icon
44
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.12M 0.2%
169,039
– –
2020 Q1
1 quarter
PYPL icon
45
PayPal
PYPL
$48.6B
$871K 0.15%
5,000
-17,500
-78% -$2.42M
2020 Q1
1 quarter
ORTX
46
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$751K 0.13%
12,520
– –
2020 Q1
1 quarter
HYACW icon
47
DELISTED
Haymaker Acquisition Corp. II Warrant
HYACW
$520K 0.09%
333,333
– –
2020 Q1
1 quarter
LBTYA icon
48
Liberty Global Class A
LBTYA
$2.75B
$503K 0.09%
22,989
– –
2019 Q4
2 quarters
EOSEW icon
49
Eos Energy Enterprises Warrant
EOSEW
$15.9M
$438K 0.08%
+250,000
New +$272K
2020 Q2
0 quarters
BATRK icon
50
Atlanta Braves Holdings Series B
BATRK
$3.21B
$409K 0.07%
+20,717
New +$411K
2020 Q2
0 quarters
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q2 2020 Portfolio in Review

As of Q2 2020, Bleichroeder LP held 79 positions worth $565M, up 48% from $383M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP deployed $64.7M of net new capital in Q2 2020, opening 22 new positions and adding to 9 existing holdings. Its largest new stake was Royalty Pharma: 1,115,980 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 20% a quarter earlier, followed by Industrials and Miscellaneous.

On the sell side, the largest reduction was Filana Therapeutics, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q2 2020 buy was Royalty Pharma: 1,115,980 shares worth $54.2M.
  • Bleichroeder LP added most to LiqTech in Q2 2020, an estimated $4.94M increase.
  • Bleichroeder LP's biggest Q2 2020 reduction was Filana Therapeutics, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Welltower in Q2 2020, selling an estimated $6.7M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $565M portfolio in Q2 2020.
  • Bleichroeder LP opened 22 new positions and closed 5 in Q2 2020.
  • Bleichroeder LP's portfolio value rose 48% quarter-over-quarter to $565M.

Based on Bleichroeder LP's 13F filing for Q2 2020, filed 12 Aug 2020.